{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T02:01:59Z","timestamp":1779847319530,"version":"3.53.1"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T00:00:00Z","timestamp":1775520000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T00:00:00Z","timestamp":1779840000000},"content-version":"vor","delay-in-days":50,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"BluGenes Foundation"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neuroinflammation"],"DOI":"10.1186\/s12974-026-03783-6","type":"journal-article","created":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T13:54:05Z","timestamp":1775570045000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A novel humanized mouse model exhibits neurobehavioral impairments and recapitulates key neuropathological features of infantile Tay-Sachs disease"],"prefix":"10.1186","volume":"23","author":[{"given":"Lujaina","family":"Elbakr","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgiana","family":"Forguson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong Anh","family":"Truong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua E.","family":"Hung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wing Suen","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong-Kyu","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reid A.","family":"Brewer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sydney","family":"Steiman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toan Q.","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajoy","family":"Vincent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evgueni A.","family":"Ivakine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,7]]},"reference":[{"key":"3783_CR1","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1016\/j.jmb.2006.04.004","volume":"359","author":"MJ Lemieux","year":"2006","unstructured":"Lemieux MJ, Mark BL, Cherney MM, Withers SG, Mahuran DJ, James MN. Crystallographic structure of human beta-hexosaminidase a: interpretation of tay-sachs mutations and loss of GM2 ganglioside hydrolysis. J Mol Biol. 2006;359:913\u201329.","journal-title":"J Mol Biol"},{"key":"3783_CR2","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1093\/glycob\/cwp183","volume":"20","author":"MB Tropak","year":"2010","unstructured":"Tropak MB, Bukovac SW, Rigat BA, Yonekawa S, Wakarchuk W, Mahuran DJ. A sensitive fluorescence-based assay for monitoring GM2 ganglioside hydrolysis in live patient cells and their lysates. Glycobiology. 2010;20:356\u201365.","journal-title":"Glycobiology"},{"key":"3783_CR3","doi-asserted-by":"publisher","first-page":"572965","DOI":"10.3389\/fnins.2020.572965","volume":"14","author":"S Sipione","year":"2020","unstructured":"Sipione S, Monyror J, Galleguillos D, Steinberg N, Kadam V. Gangliosides in the brain: physiology, pathophysiology and therapeutic applications. Front Neurosci. 2020;14:572965.","journal-title":"Front Neurosci"},{"key":"3783_CR4","doi-asserted-by":"publisher","first-page":"6213","DOI":"10.3390\/ijms21176213","volume":"21","author":"AF Leal","year":"2020","unstructured":"Leal AF, Benincore-Florez E, Solano-Galarza D, Garzon Jaramillo RG, Echeverri-Pena OY, Suarez DA, Almeciga-Diaz CJ, Espejo-Mojica AJ. GM2 gangliosidoses: clinical features, pathophysiological aspects, and current therapies. Int J Mol Sci. 2020;21:6213\u201340.","journal-title":"Int J Mol Sci"},{"key":"3783_CR5","doi-asserted-by":"publisher","first-page":"906647","DOI":"10.3389\/fphar.2022.906647","volume":"13","author":"JA Picache","year":"2022","unstructured":"Picache JA, Zheng W, Chen CZ. Therapeutic Strategies For Tay-Sachs Disease. Front Pharmacol. 2022;13:906647.","journal-title":"Front Pharmacol"},{"key":"3783_CR6","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.3389\/fphys.2018.01663","volume":"9","author":"VV Solovyeva","year":"2018","unstructured":"Solovyeva VV, Shaimardanova AA, Chulpanova DS, Kitaeva KV, Chakrabarti L, Rizvanov AA. New approaches to Tay-Sachs disease therapy. Front Physiol. 2018;9:1663.","journal-title":"Front Physiol"},{"key":"3783_CR7","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/s41421-021-00276-z","volume":"7","author":"Y Qian","year":"2021","unstructured":"Qian Y, Zhao D, Sui T, Chen M, Liu Z, Liu H, Zhang T, Chen S, Lai L, Li Z. Efficient and precise generation of Tay-Sachs disease model in rabbit by prime editing system. Cell Discov. 2021;7:50.","journal-title":"Cell Discov"},{"key":"3783_CR8","first-page":"1071","volume":"51","author":"GA McDowell","year":"1992","unstructured":"McDowell GA, Mules EH, Fabacher P, Shapira E, Blitzer MG. The presence of two different infantile Tay-Sachs disease mutations in a Cajun population. Am J Hum Genet. 1992;51:1071\u20137.","journal-title":"Am J Hum Genet"},{"key":"3783_CR9","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1002\/mgg3.37","volume":"1","author":"JD Hoffman","year":"2013","unstructured":"Hoffman JD, Greger V, Strovel ET, Blitzer MG, Umbarger MA, Kennedy C, Bishop B, Saunders P, Porreca GJ, Schienda J, et al. Next-generation DNA sequencing of HEXA: a step in the right direction for carrier screening. Mol Genet Genomic Med. 2013;1:260\u20138.","journal-title":"Mol Genet Genomic Med"},{"key":"3783_CR10","doi-asserted-by":"publisher","first-page":"102401","DOI":"10.1016\/j.omtn.2024.102401","volume":"36","author":"JE Hung","year":"2025","unstructured":"Hung JE, Brewer RA, Elbakr L, Mollica A, Forguson G, Chan WS, Ivakine EA. Precise template-free correction restores gene function in Tay-Sachs disease while reframing is ineffective. Mol Ther Nucleic Acids. 2025;36:102401.","journal-title":"Mol Ther Nucleic Acids"},{"key":"3783_CR11","first-page":"716","volume":"56","author":"DJ Boles","year":"1995","unstructured":"Boles DJ, Proia RL. The molecular basis of HEXA mRNA deficiency caused by the most common Tay-Sachs disease mutation. Am J Hum Genet. 1995;56:716\u201324.","journal-title":"Am J Hum Genet"},{"key":"3783_CR12","doi-asserted-by":"publisher","first-page":"9975","DOI":"10.1073\/pnas.91.21.9975","volume":"91","author":"S Yamanaka","year":"1994","unstructured":"Yamanaka S, Johnson MD, Grinberg A, Westphal H, Crawley JN, Taniike M, Suzuki K, Proia RL. Targeted disruption of the Hexa gene results in mice with biochemical and pathologic features of Tay-Sachs disease. Proc Natl Acad Sci U S A. 1994;91:9975\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3783_CR13","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.expneurol.2017.09.012","volume":"299","author":"V Seyrantepe","year":"2018","unstructured":"Seyrantepe V, Demir SA, Timur ZK, Von Gerichten J, Marsching C, Erdemli E, Oztas E, Takahashi K, Yamaguchi K, Ates N, et al. Murine Sialidase Neu3 facilitates GM2 degradation and bypass in mouse model of Tay-Sachs disease. Exp Neurol. 2018;299:26\u201341.","journal-title":"Exp Neurol"},{"key":"3783_CR14","doi-asserted-by":"crossref","unstructured":"Allende ML, Kono M, Lee YT, Olmsted SM, Huso V, Bakir JY, Pratto F, Li C, Byrnes C, Tuymetova G et al. CNS-targeted base editing of the major late-onset Tay-Sachs mutation alleviates disease in mice. J Clin Invest. 2025;135:e183434.","DOI":"10.1172\/JCI183434"},{"key":"3783_CR15","unstructured":"Barker EN, Ashiri M, Saville JT, Hemming R, Furletti N, Dhume SH, Yu S, Anjos E, Wu X, Fresnoza A et al. Generation of mice with combined Hexa Gly269Ser KI or KO and Neu3 KO alleles to create new models of GM2 gangliosidoses. Biol Open. 2025."},{"key":"3783_CR16","doi-asserted-by":"publisher","first-page":"17608","DOI":"10.1038\/s41598-017-17962-2","volume":"7","author":"LJ Duan","year":"2017","unstructured":"Duan LJ, Pan SJ, Sato TN, Fong GH. Retinal angiogenesis regulates astrocytic differentiation in neonatal mouse retinas by oxygen dependent mechanisms. Sci Rep. 2017;7:17608\u201324.","journal-title":"Sci Rep"},{"key":"3783_CR17","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1186\/s12974-020-01947-6","volume":"17","author":"SA Demir","year":"2020","unstructured":"Demir SA, Timur ZK, Ates N, Martinez LA, Seyrantepe V. GM2 ganglioside accumulation causes neuroinflammation and behavioral alterations in a mouse model of early onset Tay-Sachs disease. J Neuroinflammation. 2020;17:277\u201395.","journal-title":"J Neuroinflammation"},{"key":"3783_CR18","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.tins.2015.04.003","volume":"38","author":"Z Yang","year":"2015","unstructured":"Yang Z, Wang KK. Glial fibrillary acidic protein: from intermediate filament assembly and gliosis to neurobiomarker. Trends Neurosci. 2015;38:364\u201374.","journal-title":"Trends Neurosci"},{"key":"3783_CR19","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.pneurobio.2011.01.005","volume":"93","author":"J Middeldorp","year":"2011","unstructured":"Middeldorp J, Hol EM. GFAP in health and disease. Prog Neurobiol. 2011;93:421\u201343.","journal-title":"Prog Neurobiol"},{"key":"3783_CR20","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.ceb.2015.02.004","volume":"32","author":"EM Hol","year":"2015","unstructured":"Hol EM, Pekny M. Glial fibrillary acidic protein (GFAP) and the astrocyte intermediate filament system in diseases of the central nervous system. Curr Opin Cell Biol. 2015;32:121\u201330.","journal-title":"Curr Opin Cell Biol"},{"key":"3783_CR21","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/S0165-5728(85)80063-1","volume":"8","author":"LF Eng","year":"1985","unstructured":"Eng LF. Glial fibrillary acidic protein (GFAP): the major protein of glial intermediate filaments in differentiated astrocytes. J Neuroimmunol. 1985;8:203\u201314.","journal-title":"J Neuroimmunol"},{"key":"3783_CR22","doi-asserted-by":"publisher","first-page":"6244","DOI":"10.1073\/pnas.77.10.6244","volume":"77","author":"H Korn","year":"1980","unstructured":"Korn H, Axelrad H. Electrical inhibition of Purkinje cells in the cerebellum of the rat. Proc Natl Acad Sci U S A. 1980;77:6244\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3783_CR23","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1007\/s12311-018-0985-7","volume":"17","author":"T Hirano","year":"2018","unstructured":"Hirano T. Purkinje Neurons: Development, Morphology, and Function. Cerebellum. 2018;17:699\u2013700.","journal-title":"Cerebellum"},{"key":"3783_CR24","doi-asserted-by":"publisher","first-page":"1426653","DOI":"10.3389\/fncom.2024.1426653","volume":"18","author":"EM Fernandez Santoro","year":"2024","unstructured":"Fernandez Santoro EM, Karim A, Warnaar P, De Zeeuw CI, Badura A, Negrello M. Purkinje cell models: past, present and future. Front Comput Neurosci. 2024;18:1426653.","journal-title":"Front Comput Neurosci"},{"key":"3783_CR25","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1038\/199655a0","volume":"199","author":"P Andersen","year":"1963","unstructured":"Andersen P, Eccles J, Voorhoeve PE. Inhibitory Synapses on Somas of Purkinje Cells in the Cerebellum. Nature. 1963;199:655\u20136.","journal-title":"Nature"},{"key":"3783_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/hmg\/5.1.1","volume":"5","author":"D Phaneuf","year":"1996","unstructured":"Phaneuf D, Wakamatsu N, Huang JQ, Borowski A, Peterson AC, Fortunato SR, Ritter G, Igdoura SA, Morales CR, Benoit G, et al. Dramatically different phenotypes in mouse models of human Tay-Sachs and Sandhoff diseases. Hum Mol Genet. 1996;5:1\u201314.","journal-title":"Hum Mol Genet"},{"key":"3783_CR27","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1093\/hmg\/11.11.1343","volume":"11","author":"R Myerowitz","year":"2002","unstructured":"Myerowitz R, Lawson D, Mizukami H, Mi Y, Tifft CJ, Proia RL. Molecular pathophysiology in Tay-Sachs and Sandhoff diseases as revealed by gene expression profiling. Hum Mol Genet. 2002;11:1343\u201350.","journal-title":"Hum Mol Genet"},{"key":"3783_CR28","doi-asserted-by":"publisher","first-page":"e1233","DOI":"10.1542\/peds.2011-0078","volume":"128","author":"AE Bley","year":"2011","unstructured":"Bley AE, Giannikopoulos OA, Hayden D, Kubilus K, Tifft CJ, Eichler FS. Natural history of infantile G(M2) gangliosidosis. Pediatrics. 2011;128:e1233\u20131241.","journal-title":"Pediatrics"},{"key":"3783_CR29","doi-asserted-by":"publisher","first-page":"3469","DOI":"10.1523\/JNEUROSCI.23-08-03469.2003","volume":"23","author":"JJ Barski","year":"2003","unstructured":"Barski JJ, Hartmann J, Rose CR, Hoebeek F, Morl K, Noll-Hussong M, De Zeeuw CI, Konnerth A, Meyer M. Calbindin in cerebellar Purkinje cells is a critical determinant of the precision of motor coordination. J Neurosci. 2003;23:3469\u201377.","journal-title":"J Neurosci"},{"key":"3783_CR30","doi-asserted-by":"publisher","first-page":"4","DOI":"10.3389\/neuro.03.004.2009","volume":"3","author":"G Ohtsuki","year":"2009","unstructured":"Ohtsuki G, Piochon C, Hansel C. Climbing fiber signaling and cerebellar gain control. Front Cell Neurosci. 2009;3:4.","journal-title":"Front Cell Neurosci"},{"key":"3783_CR31","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/S0896-6273(00)80079-3","volume":"16","author":"NA Hartell","year":"1996","unstructured":"Hartell NA. Strong activation of parallel fibers produces localized calcium transients and a form of LTD that spreads to distant synapses. Neuron. 1996;16:601\u201310.","journal-title":"Neuron"},{"key":"3783_CR32","doi-asserted-by":"publisher","first-page":"R544","DOI":"10.1016\/S0960-9822(06)00277-6","volume":"7","author":"AP Dawson","year":"1997","unstructured":"Dawson AP. Calcium signalling: how do IP3 receptors work? Curr Biol. 1997;7:R544\u2013547.","journal-title":"Curr Biol"},{"key":"3783_CR33","doi-asserted-by":"publisher","first-page":"2382","DOI":"10.1016\/j.neurobiolaging.2014.04.024","volume":"35","author":"M Marangoni","year":"2014","unstructured":"Marangoni M, Adalbert R, Janeckova L, Patrick J, Kohli J, Coleman MP, Conforti L. Age-related axonal swellings precede other neuropathological hallmarks in a knock-in mouse model of Huntington\u2019s disease. Neurobiol Aging. 2014;35:2382\u201393.","journal-title":"Neurobiol Aging"},{"key":"3783_CR34","doi-asserted-by":"publisher","first-page":"3984","DOI":"10.1007\/s12035-018-1353-9","volume":"56","author":"S Ruhling","year":"2019","unstructured":"Ruhling S, Kramer F, Schmutz S, Amor S, Jiangshan Z, Schmitz C, Kipp M, Hochstrasser T. Visualization of the breakdown of the axonal transport machinery: a comparative ultrastructural and immunohistochemical approach. Mol Neurobiol. 2019;56:3984\u201398.","journal-title":"Mol Neurobiol"},{"key":"3783_CR35","doi-asserted-by":"publisher","first-page":"12776","DOI":"10.1523\/JNEUROSCI.3463-09.2009","volume":"29","author":"GA Morfini","year":"2009","unstructured":"Morfini GA, Burns M, Binder LI, Kanaan NM, LaPointe N, Bosco DA, Brown RH Jr., Brown H, Tiwari A, Hayward L, et al. Axonal transport defects in neurodegenerative diseases. J Neurosci. 2009;29:12776\u201386.","journal-title":"J Neurosci"},{"key":"3783_CR36","doi-asserted-by":"publisher","first-page":"4129","DOI":"10.1038\/s41467-021-24390-4","volume":"12","author":"D Lang-Ouellette","year":"2021","unstructured":"Lang-Ouellette D, Gruver KM, Smith-Dijak A, Blot FGC, Stewart CA, de Vanssay de Blavous P, Li CH, Van Eitrem C, Rosen C, Faust PL, et al. Purkinje cell axonal swellings enhance action potential fidelity and cerebellar function. Nat Commun. 2021;12:4129\u201342.","journal-title":"Nat Commun"},{"key":"3783_CR37","first-page":"100843","volume":"30","author":"RWD Welford","year":"2022","unstructured":"Welford RWD, Farine H, Steiner M, Garzotti M, Dobrenis K, Sievers C, Strasser DS, Amraoui Y, Groenen PMA, Giugliani R, Mengel E. Plasma neurofilament light, glial fibrillary acidic protein and lysosphingolipid biomarkers for pharmacodynamics and disease monitoring of GM2 and GM1 gangliosidoses patients. Mol Genet Metab Rep. 2022;30:100843.","journal-title":"Mol Genet Metab Rep"},{"key":"3783_CR38","doi-asserted-by":"crossref","unstructured":"Singh J, Aggarwal D. Eye is a window to systemic pathology: cherry-red spot to diagnose Tay-Sachs disease. BMJ Case Rep. 2024;17:e261882.","DOI":"10.1136\/bcr-2024-261882"},{"key":"3783_CR39","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1001\/archopht.1959.00940090416011","volume":"61","author":"DG Cogan","year":"1959","unstructured":"Cogan DG, Kuwabara T. Histochemistry of the retina in tay-sachs disease. AMA Arch Ophthalmol. 1959;61:414\u201323.","journal-title":"AMA Arch Ophthalmol"},{"key":"3783_CR40","doi-asserted-by":"publisher","first-page":"435","DOI":"10.3928\/01913913-20230123-01","volume":"60","author":"T Lee","year":"2023","unstructured":"Lee T, Velez FG, Galoyan N, Prasad VK, El-Dairi MA. Optical coherence tomography findings in cherry-red spot: implications for understanding pathophysiology and visual prognosis. J Pediatr Ophthalmol Strabismus. 2023;60:435\u201340.","journal-title":"J Pediatr Ophthalmol Strabismus"},{"key":"3783_CR41","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1002\/ana.410170409","volume":"17","author":"JD Kivlin","year":"1985","unstructured":"Kivlin JD, Sanborn GE, Myers GG. The cherry-red spot in tay-sachs and other storage diseases. Ann Neurol. 1985;17:356\u201360.","journal-title":"Ann Neurol"},{"key":"3783_CR42","doi-asserted-by":"publisher","first-page":"3420","DOI":"10.1167\/iovs.05-0038","volume":"46","author":"K Sango","year":"2005","unstructured":"Sango K, Takano M, Ajiki K, Tokashiki A, Arai N, Kawano H, Horie H, Yamanaka S. Impaired neurite outgrowth in the retina of a murine model of Sandhoff disease. Invest Ophthalmol Vis Sci. 2005;46:3420\u20135.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"3783_CR43","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1097\/OPX.0000000000001181","volume":"95","author":"HB Lim","year":"2018","unstructured":"Lim HB, Sung JY, Ahn SI, Jo YJ, Kim JY. Retinal nerve fiber layer thickness in various retinal diseases. Optom Vis Sci. 2018;95:247\u201355.","journal-title":"Optom Vis Sci"},{"key":"3783_CR44","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/S0039-6257(96)80065-8","volume":"40","author":"JB Jonas","year":"1996","unstructured":"Jonas JB, Dichtl A. Evaluation of the retinal nerve fiber layer. Surv Ophthalmol. 1996;40:369\u201378.","journal-title":"Surv Ophthalmol"},{"key":"3783_CR45","first-page":"1871","volume":"17","author":"LE Pablo","year":"2011","unstructured":"Pablo LE, Garcia-Martin E, Gazulla J, Larrosa JM, Ferreras A, Santorelli FM, Benavente I, Vela A, Marin MA. Retinal nerve fiber hypertrophy in ataxia of charlevoix-saguenay patients. Mol Vis. 2011;17:1871\u20136.","journal-title":"Mol Vis"},{"key":"3783_CR46","doi-asserted-by":"crossref","unstructured":"Yildirim MA, Erden B, Tetikoglu M, Kuru O, Elcioglu M. Analysis of the retinal nerve fiber layer in retinitis pigmentosa using optic coherence tomography. J Ophthalmol 2015, 2015:157365.","DOI":"10.1155\/2015\/157365"},{"key":"3783_CR47","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1038\/eye.2008.63","volume":"23","author":"A Oishi","year":"2009","unstructured":"Oishi A, Otani A, Sasahara M, Kurimoto M, Nakamura H, Kojima H, Yoshimura N. Retinal nerve fiber layer thickness in patients with retinitis pigmentosa. Eye (Lond). 2009;23:561\u20136.","journal-title":"Eye (Lond)"},{"key":"3783_CR48","first-page":"1363","volume":"29","author":"P Ekstrom","year":"1988","unstructured":"Ekstrom P, Sanyal S, Narfstrom K, Chader GJ, van Veen T. Accumulation of glial fibrillary acidic protein in muller radial glia during retinal degeneration. Invest Ophthalmol Vis Sci. 1988;29:1363\u201371.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"3783_CR49","doi-asserted-by":"publisher","first-page":"484","DOI":"10.3389\/fncel.2015.00484","volume":"9","author":"L Fernandez-Sanchez","year":"2015","unstructured":"Fernandez-Sanchez L, Lax P, Campello L, Pinilla I, Cuenca N. Astrocytes and muller cell alterations during retinal degeneration in a transgenic rat model of retinitis pigmentosa. Front Cell Neurosci. 2015;9:484\u2013500.","journal-title":"Front Cell Neurosci"}],"container-title":["Journal of Neuroinflammation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12974-026-03783-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-026-03783-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-026-03783-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T01:04:44Z","timestamp":1779843884000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12974-026-03783-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,7]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3783"],"URL":"https:\/\/doi.org\/10.1186\/s12974-026-03783-6","relation":{},"ISSN":["1742-2094"],"issn-type":[{"value":"1742-2094","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,7]]},"assertion":[{"value":"11 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal studies were performed under protocols approved by the TCP Animal Care Committee, following the Animals for Research Act (Ontario) and the ethical standards of the Canadian Council on Animal Care.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"174"}}